Biliary Tract Diseases D001660

Diseases [C] » Digestive System Diseases [C06] » Biliary Tract Diseases

Description

Diseases in any part of the BILIARY TRACT including the BILE DUCTS and the GALLBLADDER.   MeSH

Subtype Terms (6)

Bile Duct Diseases
10 drugs (5 approved, 5 experimental)

Bile Reflux
7 drugs (4 approved, 3 experimental)

Biliary Tract Neoplasms
131 drugs (59 approved, 72 experimental)

Cholelithiasis
16 drugs (14 approved, 2 experimental)

Gallbladder Diseases
20 drugs (16 approved, 4 experimental)

Postcholecystectomy Syndrome
1 experimental drug


Approved Indicated Drugs (2)

Phase 4 Indicated Drugs (2)

Phase 3 Indicated Drugs (1)

Other Experimental Indicated Drugs (2)


Organization Involved with Phase 4 Indications (1)

Organization Involved with Phase 3 Indications (3)

Organization Involved with Other Experimental Indications (1)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.